Medifast (MED) came out with quarterly earnings of $3.46 per share, beating the Zacks Consensus Estimate of $2.72 per share. This compares to earnings of $1.93 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 27.21%. A quarter ago, it was expected that this weight-loss company would post earnings of $2.36 per share when it actually produced earnings of $2.36, delivering no surprise.
Over the last four quarters, the company has surpassed consensus EPS estimates three times.
Medifast, which belongs to the Zacks Food - Miscellaneous industry, posted revenues of $340.67 million for the quarter ended March 2021, surpassing the Zacks Consensus Estimate by 18.71%. This compares to year-ago revenues of $178.46 million. The company has topped consensus revenue estimates four times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.